Atherotech Inc.

January 30, 2012 — Expanded cholesterol assessment of moderate risk patients can play an important role in identifying ...

January 30, 2012

February 3, 2011 – Behrman Capital, a private equity investment firm based in New York and San Francisco, has acquired ...

February 03, 2011

March 3, 2010 – Two poster sessions will highlight research of Atherotech’s VAP Cholesterol Test at the American College ...

March 03, 2010

January 20, 2010 – LDL is not the only "bad cholesterol" according to a new study. A lipoprotein in the bloodstream ...

January 19, 2010

August, 13, 2009 – Atherotech Inc. this week added two new cardiometabolic tests – the PLAC Test for identification of ...

August 13, 2009

March 30, 2009 – At ACC 2009, Atherotech Inc., developer of the VAP Cholesterol Test, debuted new cardiovascular and ...

March 30, 2009

Atherotech Inc. is a cardio-diagnostic laboratory focusing on cardiovascular tests to better assess both risk and ...

February 11, 2009

February 2, 2009 - A recent study published in Clinical Cardiology revealed that "emerging risk factors," including ...

February 02, 2009

November 7, 2008 - Atherotech Inc. announced it will be exhibiting its VAP Cholesterol Test at the American Heart ...

November 06, 2008

Related Content